Our present study has also found that NIFK involvement in HNSCC progression is linked with immune response and immune associated pathways (Figure 7), hinting that NIFK is also a potential therapeutic target for immunotherapy for HNSCC, although future work is required to validate this conjecture. Here, NIFK is linked to head and neck squamous cell carcinoma.